当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:266.68亿  总市值:266.68亿
流通股本:28.04亿   总股本:28.04亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,535,506,477.8526,284,830,929.5220,017,362,283.1713,004,397,294.89
  收到的税费返还148,716,993.34564,637,199.44437,089,373.63255,379,073.62
  收到其他与经营活动有关的现金35,537,858.65314,266,906.41259,273,351.77191,153,397.33
  经营活动现金流入小计6,719,761,329.8427,163,735,035.3720,713,725,008.5713,450,929,765.84
  购买商品、接受劳务支付的现金6,918,296,320.5619,183,664,918.4413,161,667,283.299,083,489,211.25
  支付给职工以及为职工支付的现金506,769,238.421,888,800,255.381,386,666,122.25904,015,836.36
  支付的各项税费122,889,775.631,064,967,949.58838,239,192.44597,189,446.61
  支付其他与经营活动有关的现金327,363,483.781,017,042,265.74615,992,412.25553,444,050.99
  经营活动现金流出小计7,875,318,818.3923,154,475,389.1416,002,565,010.2311,138,138,545.21
  经营活动产生的现金流量净额-1,155,557,488.554,009,259,646.234,711,159,998.342,312,791,220.63
二、投资活动产生的现金流量:
  收回投资收到的现金240,191,771.749,416,904.1124,295,712.5173,892,375.14
  取得投资收益收到的现金16,232,473.0889,022,905.5142,580,649.6116,498,979
  处置固定资产、无形资产和其他长期资产收回的现金净额927,536.213,929,974.232,152,974.231,245,921.8
  投资活动现金流入小计257,351,780.99142,369,783.8569,029,336.3591,637,275.94
  购建固定资产、无形资产和其他长期资产支付的现金522,609,583.682,085,097,608.711,523,816,613.121,087,107,997.28
  投资支付的现金261,022,618.051,021,970,127.421,915,477,856.391,944,967,826.4
  取得子公司及其他营业单位支付的现金-154,418,006.87200,613,641.06-
  支付其他与投资活动有关的现金624,339.925,064,758.893,803,296.412,859,048.14
  投资活动现金流出小计784,256,541.633,286,550,501.893,643,711,406.983,034,934,871.82
  投资活动产生的现金流量净额-526,904,760.64-3,144,180,718.04-3,574,682,070.63-2,943,297,595.88
三、筹资活动产生的现金流量:
  取得借款收到的现金1,040,647,9955,303,483,203.634,197,857,434.782,874,965,205.64
  收到其他与筹资活动有关的现金216,991,590.33631,857,578.29546,103,814.09428,515,211.85
  筹资活动现金流入小计1,257,639,585.335,935,340,781.924,743,961,248.873,303,480,417.49
  偿还债务支付的现金957,100,0005,009,880,000.023,928,170,000.012,629,070,000
  分配股利、利润或偿付利息支付的现金13,136,936.451,255,746,825.791,242,864,719.661,228,810,522.76
  支付其他与筹资活动有关的现金190,391,605.65677,245,874.35614,073,851.66255,748,337.46
  筹资活动现金流出小计1,160,628,542.16,942,872,700.165,785,108,571.334,113,628,860.22
  筹资活动产生的现金流量净额97,011,043.23-1,007,531,918.24-1,041,147,322.46-810,148,442.73
四、汇率变动对现金及现金等价物的影响-31,457,118.4317,029,234.725,528,099.831,539,177.23
五、现金及现金等价物净增加额-1,616,908,324.39-125,423,755.35120,858,705.05-1,409,115,640.75
  加:期初现金及现金等价物余额4,006,435,846.794,131,859,602.144,131,859,602.144,131,859,602.14
  期末现金及现金等价物余额2,389,527,522.44,006,435,846.794,252,718,307.192,722,743,961.39
补充资料:
  净利润-3,280,879,912.1-1,767,950,116.89
  资产减值准备-36,034,934.84-9,236,606.64
  固定资产和投资性房地产折旧-1,352,389,043.85-663,310,890.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,352,389,043.85-663,310,890.94
  无形资产摊销-49,442,167.88-20,437,708.39
  长期待摊费用摊销-41,023,855.2-18,080,269.41
  处置固定资产、无形资产和其他长期资产的损失--834,727.21--438,552.05
  固定资产报废损失-37,764,435.04-6,570,163.08
  公允价值变动损失--32,838,480.38--16,016,844.67
  财务费用-19,056,345.85--737,611.57
  投资损失--57,847,648.05--29,250,766.79
  递延所得税--4,837,561.2--20,007,640.1
  其中:递延所得税资产减少-16,747,667.25--19,972,579.93
    递延所得税负债增加--21,585,228.45--35,060.17
  存货的减少-32,921,201.66-208,943,971.2
  经营性应收项目的减少-291,262,779.09--3,689,852.79
  经营性应付项目的增加--197,284,586.92--313,556,197.56
  其他--831,441,015.05--
  现金的期末余额-4,006,435,846.79-2,722,743,961.39
  减:现金的期初余额-4,131,859,602.14-4,131,859,602.14
  现金及现金等价物的净增加额--125,423,755.35--1,409,115,640.75
公告日期2026-04-222026-04-222025-10-302025-08-20
审计意见(境内)标准无保留意见
TOP↑